ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 63 filers reported holding ADC THERAPEUTICS SA in Q4 2022. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,176,000 | -39.4% | 451,637 | -0.0% | 0.00% | -33.3% |
| Q2 2022 | $3,592,000 | -42.0% | 451,827 | +7.2% | 0.00% | -25.0% |
| Q1 2022 | $6,189,000 | -27.3% | 421,297 | +0.0% | 0.00% | -20.0% |
| Q4 2021 | $8,508,000 | -17.5% | 421,174 | +10.9% | 0.01% | -28.6% |
| Q3 2021 | $10,314,000 | +11.5% | 379,748 | -0.1% | 0.01% | +16.7% |
| Q2 2021 | $9,254,000 | -0.0% | 380,049 | +0.2% | 0.01% | -14.3% |
| Q1 2021 | $9,255,000 | -15.0% | 379,137 | +11.5% | 0.01% | -12.5% |
| Q4 2020 | $10,886,000 | +24.5% | 340,089 | +28.3% | 0.01% | 0.0% |
| Q3 2020 | $8,747,000 | – | 265,138 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,186,215 | $5,718,000 | 3.34% |
| Blue Owl Capital Holdings LP | 733,568 | $3,536,000 | 1.53% |
| Redmile Group, LLC | 7,512,029 | $36,208,000 | 1.40% |
| GCM Grosvenor Holdings, LLC | 735,471 | $3,545,000 | 0.84% |
| Prosight Management, LP | 247,630 | $1,194,000 | 0.64% |
| Indie Asset Partners, LLC | 93,839 | $452,000 | 0.46% |
| MPM BioImpact LLC | 334,384 | $1,612,000 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,390,297 | $11,521,000 | 0.23% |
| Eventide Asset Management | 1,879,959 | $9,061,000 | 0.18% |
| APOGEM CAPITAL LLC | 17,405 | $84,000 | 0.08% |